
Samir R Kapadia MD
Interventional Cardiology
Chairman, Department of Cardiovascular Medicine, Cleveland Clinic.
Join to view full profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Dr. Kapadia is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Samir Kapadia is a cardiologist specializing in Interventional Cardiology, based in Cleveland, OH. He completed his fellowship in cardiovascular disease at Cleveland Clinic Foundation and his residency in Internal Medicine at Baylor College of Medicine. Dr. Kapadia has notable experience in pericardiocentesis, coronary artery disease, myocardial infarction, ischemic cardiomyopathy, and aortic stenosis. He has contributed to several significant publications in prestigious medical journals. He has also served as a Principal Investigator in multiple clinical trials, with particular focus on interventions related to Aortic Valve Replacement and MitraClip therapy. Among his awards are CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, and Fellow (FACC) from the American College of Cardiology.
Education & Training
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1995 - 1998
Baylor College of MedicineResidency, Internal Medicine, 1991 - 1995
N.H.L Municipal Medical CollegeClass of 1990
Certifications & Licensure
OH State Medical License 1996 - 2028
MI State Medical License 1995 - 1996
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
Clinical Trials
- Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS
- Transcatheter Aortic Valve Replacement System Pivotal Trial
- ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement Start of enrollment: 2019 Jun 10
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- The Impact of Anemia on Clinical Outcomes of Patients Above 80 Years Old Following Transcatheter Aortic Valve Replacement.Besir Besir, Carl Ammoury, Alexander Egoavil, Sada Babazade, Wajeh Abuirmaileh
Structural Heart. 2026-09-01 - Long-Term Survival After Transcatheter Aortic Valve Replacement Relative to an Age- and Comorbidity-Matched Population.Akiva Rosenzveig, Faysal Massad, Osamah Badwan, Ankit Agrawal, Samuel Reiss
JACC. Advances. 2026-08-11 - Pacemaker Implantation in Patients With Pre-Existing Bundle Branch Block Undergoing Balloon-Expandable Transcatheter Aortic Valve Replacement.Judah Rajendran, Shivabalan Kathavarayan Ramu, Carl Ammoury, Besir Besir, Akhilesh Khuttan
Structural Heart. 2026-08-01
Journal Articles
- One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveBrian Whisenant, Samir R Kapadia, Mackram F Eleid, James M Mccabe, Amar Krishnaswamy, Richard W Smalling, Charanjit S Rihal, Raj R Makkar, JAMA Cardiology
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicHanad Bashir, Khaled M Sleik, Mina K Chung, Umesh N Khot, Samir R Kapadia, JAMA Network Open
- Operational Efficiency and Effective Management in the Catheterization LaboratorySamir Kapadia, MD, ScienceDirect
Abstracts/Posters
- [Board 064] Three-Year Outcomes of Transcatheter Aortic Valve Replacement With SAPIEN-3Samir Kapadia, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
Lectures
- LAA Occlusion Plus: MitraClip, TAVR, PCI, and MoreCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Incidence, Trends, Risk Factors, and Comparison With Surgery for Early Stroke After TAVR: Reports From PARTNER and the TVT Registry (in High- and Intermediate-Risk Pat...CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Navigate Transcatheter Tricuspid Valve Replacement… Early Findings – Technology and Clinical UpdatesCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/14/2019
Authored Content
- One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020
- One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020
- Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 PandemicJuly 2020
Press Mentions
Valve Imaging Summit Offers a Practical, Case-Based Take on the Latest in Valvular Heart DiseaseNovember 14th, 2025
Cleveland Clinic Establishes Cardiovascular Genomics Initiative to Advance Precision Heart CareOctober 29th, 2025
Cleveland Clinic Collaborates with DASI Simulations to Create AI-Powered Technology for Structural Heart CareOctober 16th, 2025
Professional Memberships
- Member
Other Languages
- Hindi, Gujarati, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:








